AB 968 California Assembly · 2025-2026 Regular Session

Contraceptives.

Summary
Existing law, the Pharmacy Law, establishes, in the Department of Consumer Affairs, the California State Board of Pharmacy to license and regulate the practice of pharmacy. Existing law authorizes a physician and surgeon, nurse practitioner, registered nurse, and specified other health care practitioners acting within the scope of their practice to use a self-screening tool to identify patient risk factors for the use of self-administered hormonal contraceptives by a patient and, after examination, to prescribe, furnish, or dispense self-administered hormonal contraceptives to the patient. This bill would, instead, make those provisions applicable to contraceptives. Existing law authorizes a pharmacist to furnish self-administered hormonal contraceptives in accordance with standardized procedures or protocols developed and approved by both the California State Board of Pharmacy and the Medical Board of California, in consultation with specified other entities. This bill would authorize a pharmacist to also furnish federal Food and Drug Administration-approved nonhormonal contraceptives in accordance with those standardized procedures or protocols. The bill would require a pharmacist, for each federal Food and Drug Administration-approved nonhormonal contraceptives initiated, to provide the recipient with a standardized fact sheet, as specified. Existing law prohibits a pharmacist, pharmacist's employer, or pharmacist's agent from directly charging a patient a separate consultation fee for emergency contraception drug therapy services and requires the pharmacist to disclose the total retail price of the emergency contraception drug therapy. Existing law makes those provisions inoperative for dedicated emergency contraception drugs if these drugs are reclassified as over-the-counter products by the federal Food and Drug Administration. This bill would delete those provisions. Existing law requires a pharmacist to dispense, at a patient's request, up to a 12-month supply of an FDA-approved, self-administered hormonal contraceptive. This bill would, instead, make those provisions applicable to contraceptives. This bill would make related conforming changes.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2025
Committee Review
Aug 2025
Assembly Passage
May 2025
Senate Passage
Governor
Introduced Feb 20, 2025 Last action Sep 13, 2025
Floor votes · Assembly May 27, 2025

How they voted

760
Passed · 2 other
Total votes 78
May 27, 2025
D Democratic59
58 Yea 1
98% Yea
R Republican19
18 Yea 1
94% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
23
Key actions
11
Committee
14
Amendments
3
Aug 19, 2025
Upper · Passed
From committee: Be ordered to second reading pursuant to Senate Rule 28.8.
upper
Jul 14, 2025
Upper · Passed
From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (July 14). Re-referred to Com. on APPR.
upper
Jul 9, 2025
Introduced
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
upper
Jul 3, 2025
Upper · Passed
In committee: Set, first hearing. Hearing canceled at the request of author.
upper
Jun 23, 2025
Upper · Passed
In committee: Hearing postponed by committee.
upper
Jun 11, 2025
Upper · Passed
In committee: Hearing postponed by committee.
upper
Jun 9, 2025
Introduced
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
upper
Jun 4, 2025
Committee
Referred to Com. on B. P. & E.D.
upper
May 27, 2025
Lower · Passed
Read third time. Passed. Ordered to the Senate. (Ayes 77. Noes 0. Page 1737.)
lower
May 21, 2025
Lower · Passed
From committee: Do pass. (Ayes 15. Noes 0.) (May 21).
lower
May 14, 2025
Lower · Passed
In committee: Hearing postponed by committee.
lower
Apr 29, 2025
Lower · Passed
From committee: Do pass and re-refer to Com. on APPR. (Ayes 17. Noes 0.) (April 29). Re-referred to Com. on APPR.
lower
Apr 10, 2025
Committee
Re-referred to Com. on B. & P. pursuant to Assembly Rule 96.
lower
Apr 8, 2025
Committee
Re-referred to Com. on TRANS.
lower
Apr 7, 2025
Introduced
From committee chair, with author's amendments: Amend, and re-refer to Com. on TRANS. Read second time and amended.
lower
Apr 7, 2025
Lower · Passed
In committee: Set, first hearing. Hearing canceled at the request of author.
lower
Mar 10, 2025
Committee
Referred to Com. on TRANS.
lower
Feb 21, 2025
Lower · Passed
From printer. May be heard in committee March 23.
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Tasha Boerner
Tasha Boerner
DDemocratic
CA
77